These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 29850609)
1. Assessment of Vitamin D-Binding Protein and Early Prediction of Nephropathy in Type 2 Saudi Diabetic Patients. Fawzy MS; Abu AlSel BT J Diabetes Res; 2018; 2018():8517929. PubMed ID: 29850609 [TBL] [Abstract][Full Text] [Related]
2. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus. Shoukry A; Bdeer Sel-A; El-Sokkary RH Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579 [TBL] [Abstract][Full Text] [Related]
3. Association of Circulating Vitamin D, VDBP, and Vitamin D Receptor Expression with Severity of Diabetic Nephropathy in a Group of Saudi Type 2 Diabetes Mellitus Patients. Fawzy MS; Beladi FIA Clin Lab; 2018 Oct; 64(10):1623-1633. PubMed ID: 30336516 [TBL] [Abstract][Full Text] [Related]
4. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy. Li Z; Xu Y; Liu X; Nie Y; Zhao Z Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347 [TBL] [Abstract][Full Text] [Related]
5. Vitamin D-Binding Protein Clearance Ratio Is Significantly Associated with Glycemic Status and Diabetes Complications in a Predominantly Vitamin D-Deficient Population. Abdella NA; Mojiminiyi OA J Diabetes Res; 2018; 2018():6239158. PubMed ID: 29888290 [TBL] [Abstract][Full Text] [Related]
6. Elevated urinary level of vitamin D-binding protein as a novel biomarker for diabetic nephropathy. Tian XQ; Zhao LM; Ge JP; Zhang Y; Xu YC Exp Ther Med; 2014 Feb; 7(2):411-416. PubMed ID: 24396416 [TBL] [Abstract][Full Text] [Related]
7. Urinary podocalyxin positive-element occurs in the early stage of diabetic nephropathy and is correlated with a clinical diagnosis of diabetic nephropathy. Ye H; Bai X; Gao H; Li L; Wu C; Sun X; Zhang C; Shen Y; Zhang J; Lu Z J Diabetes Complications; 2014; 28(1):96-100. PubMed ID: 24075693 [TBL] [Abstract][Full Text] [Related]
8. Zinc alpha 2 glycoprotein as an early biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus. Elsheikh M; Elhefnawy KA; Emad G; Ismail M; Borai M J Bras Nefrol; 2019; 41(4):509-517. PubMed ID: 30897192 [TBL] [Abstract][Full Text] [Related]
9. Assessment of two novel renal tubular proteins in type 2 diabetic patients with nephropathy. Abdel Ghafar MT; Shalaby KH; Okda HI; Abo El Gheit RE; Soliman NA; Keshk WA J Investig Med; 2020 Mar; 68(3):748-755. PubMed ID: 31722957 [TBL] [Abstract][Full Text] [Related]
10. Utility of urinary biomarkers as a diagnostic tool for early diabetic nephropathy in patients with type 2 diabetes mellitus. Vijay S; Hamide A; Senthilkumar GP; Mehalingam V Diabetes Metab Syndr; 2018 Sep; 12(5):649-652. PubMed ID: 29673928 [TBL] [Abstract][Full Text] [Related]
11. Assessing urinary levels of IL-18, NGAL and albumin creatinine ratio in patients with diabetic nephropathy. Sueud T; Hadi NR; Abdulameer R; Jamil DA; Al-Aubaidy HA Diabetes Metab Syndr; 2019; 13(1):564-568. PubMed ID: 30641767 [TBL] [Abstract][Full Text] [Related]
12. Periostin as a tissue and urinary biomarker of renal injury in type 2 diabetes mellitus. Satirapoj B; Tassanasorn S; Charoenpitakchai M; Supasyndh O PLoS One; 2015; 10(4):e0124055. PubMed ID: 25884625 [TBL] [Abstract][Full Text] [Related]
13. Plasma type IV collagen levels as a potential biomarker for early detection of nephropathy in diabetes mellitus patients. Atita FA; El-Hagrasy HA; Hassan MM; Esawy HS Egypt J Immunol; 2024 Jul; 31(3):150-160. PubMed ID: 38996049 [TBL] [Abstract][Full Text] [Related]
14. Correlation between urine vitamin D Huang Y; Chen S; Dai Q; Zhang H; Liu Y Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Jan; 48(1):40-48. PubMed ID: 36935176 [TBL] [Abstract][Full Text] [Related]
15. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy. Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462 [TBL] [Abstract][Full Text] [Related]
16. Elevated urinary D-lactate levels in patients with diabetes and microalbuminuria. Chou CK; Lee YT; Chen SM; Hsieh CW; Huang TC; Li YC; Lee JA J Pharm Biomed Anal; 2015 Dec; 116():65-70. PubMed ID: 26166004 [TBL] [Abstract][Full Text] [Related]
17. Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus. Wang QY; Chen FQ Diabetes Res Clin Pract; 2009 Feb; 83(2):215-9. PubMed ID: 19097668 [TBL] [Abstract][Full Text] [Related]
18. Adipokine zinc-alpha-2-glycoprotein as a novel urinary biomarker presents earlier than microalbuminuria in diabetic nephropathy. Wang Y; Li YM; Zhang S; Zhao JY; Liu CY J Int Med Res; 2016 Apr; 44(2):278-86. PubMed ID: 26857862 [TBL] [Abstract][Full Text] [Related]
19. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function. Chen CC; Susanto H; Chuang WH; Liu TY; Wang CH Cardiovasc Diabetol; 2016 Jan; 15():3. PubMed ID: 26739836 [TBL] [Abstract][Full Text] [Related]
20. Performance of urinary vitamin D-binding protein in diabetic kidney disease: a meta-analysis. Chen H; Ni L; Wu X Ren Fail; 2023; 45(2):2256415. PubMed ID: 37870829 [No Abstract] [Full Text] [Related] [Next] [New Search]